QuEEN
Quantitative and Engineered Elimination of Neosubstrates, a proprietary protein degradation platform technology.
Source: Swiss Venture Capital Report 2022 (Swiss Venture Capital Report (startupticker)) · p.76
Have a question about QuEEN? Ask the AI, answers cite the source.